Agilent Technologies, Inc.
$122.3
▲
0.17%
2026-04-22 10:12:13
www.agilent.com
NYQ: A
Explore Agilent Technologies, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$34.7 B
Current Price
$122.3
52W High / Low
$160.27 / $99.12
Stock P/E
26.99
Book Value
$24.44
Dividend Yield
0.84%
ROCE
14.25%
ROE
19.95%
Face Value
—
EPS
$4.53
Exp Qtr EPS
—
Sector
Healthcare
Industry
Diagnostics & Research
Employees
18,000
Beta
1.3
Debt / Equity
51.39
Current Ratio
2.07
Quick Ratio
1.52
Forward P/E
17.48
Price / Sales
4.61
Enterprise Value
$34.31 B
EV / EBITDA
17.41
EV / Revenue
4.86
Rating
Buy
Target Price
$161.94
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
- Meaningful dividend yield is available.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | BillionToOne, Inc. | $86.97 | 489.81 | $3.65 B | — | 2.74% | 2.3% | $138.7 / $61.96 | $10.48 |
| 2. | Guardant Health, Inc. | $90.8 | — | $11.97 B | — | -25.56% | 348.42% | $120.74 / $36.36 | $-0.76 |
| 3. | CareDx, Inc. | $21.29 | — | $1.11 B | — | -7.75% | -6.27% | $23.24 / $10.96 | $5.95 |
| 4. | Insight Molecular Diagnostics Inc. | $3.99 | — | $128.35 M | — | -223.51% | 229.65% | $8.51 / $2.33 | $-1.1 |
| 5. | Labcorp Holdings Inc. | $271.17 | 25.93 | $22.36 B | 1.07% | 9.74% | 10.51% | $293.72 / $209.38 | $104.86 |
| 6. | Fulgent Genetics, Inc. | $16.18 | — | $481.31 M | — | -8.07% | -5.51% | $31.04 / $13.46 | $35.78 |
| 7. | ICON Public Limited Company | $114.42 | 15.51 | $8.76 B | — | 8.66% | 6.27% | $211 / $66.57 | $122.25 |
Quarterly Results
Figures shown in M / B
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | |
|---|---|---|---|---|---|
| Sales | 1.8 B | 1.86 B | 1.74 B | 1.67 B | 1.68 B |
| Operating Profit | 353 M | 443 M | 360 M | 300 M | 376 M |
| Net Profit | 305 M | 434 M | 336 M | 215 M | 318 M |
| EPS in Rs | 1.08 | 1.54 | 1.19 | 0.76 | 1.13 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 6.95 B | 6.51 B | 6.83 B | 6.85 B |
| Operating Profit | 1.48 B | 1.49 B | 1.35 B | 1.62 B |
| Net Profit | 1.3 B | 1.29 B | 1.24 B | 1.25 B |
| EPS in Rs | 4.61 | 4.56 | 4.39 | 4.44 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 12.73 B | 11.85 B | 10.76 B | 10.53 B |
| Total Liabilities | 5.99 B | 5.95 B | 4.92 B | 5.23 B |
| Equity | 6.74 B | 5.9 B | 5.84 B | 5.3 B |
| Current Assets | 4.59 B | 3.96 B | 4.19 B | 3.78 B |
| Current Liabilities | 2.35 B | 1.9 B | 1.6 B | 1.86 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 1.56 B | 1.75 B | 1.77 B | 1.31 B |
| Investing CF | -394 M | -1.26 B | -310 M | -338 M |
| Financing CF | -715 M | -752 M | -930 M | -1.37 B |
| Free CF | 1.15 B | 1.37 B | 1.47 B | 1.02 B |
| Capex | -407 M | -378 M | -298 M | -291 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 6.73% | -4.73% | -0.22% | — |
| Earnings Growth % | 1.09% | 3.95% | -1.12% | — |
| Profit Margin % | 18.75% | 19.8% | 18.15% | 18.31% |
| Operating Margin % | 21.29% | 22.86% | 19.76% | 23.63% |
| Gross Margin % | 52.43% | 54.3% | 50.71% | 54.35% |
| EBITDA Margin % | 26.41% | 28.79% | 24.95% | 27.82% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-03-31 | $0.255 |
| 2026-01-06 | $0.255 |
| 2025-09-30 | $0.248 |
| 2025-07-01 | $0.248 |
| 2025-04-01 | $0.248 |
Stock Splits
No stock split history available.